Melissa (Kah Poh) Loh, MD, GRACE Guest Faculty

Melissa (Kah Poh) Loh, MD, Fellow, Department of Medicine-Hematology/Oncology, University of Rochester Medical Center, Rochester, United States
University of Rochester/Strong Memorial Hospital
Senior Fellow, Geriatric Hematology/Oncology University of Rochester/Strong Memorial Hospital

Dr. Melissa (Kah Poh) Loh is originally from Malaysia. She is currently a senior fellow in geriatric hematology/oncology at the University of Rochester/Strong Memorial Hospital in the USA. She will join the malignant hematology and geriatric oncology groups as a faculty at the University of Rochester in 2019. Dr. Loh’s primary interest is the development and evaluation of mobile health behavioral and supportive care interventions for older adults with cancer. Her other interests are 1) decision-making processes in older adults with acute myeloid leukemia; 2) disease understanding in the setting of advanced cancer, and 3) utilization of critical care therapies and palliative care. Dr. Loh is mentored by Dr. Supriya Mohile, Dr. Karen Mustian, Dr. Heidi Klepin, and Dr. Wendy Stock. Dr. Loh graduated from the Royal College of Surgeons in Ireland and completed her internship and residency at Baystate Medical Center/Tufts University School of Medicine. She is also pursuing a Master’s Degree in Clinical Investigation.

Conflict of Interest


At ASCO 2018, Dr. Melissa Loh presented a study titled: "Chance of Cure in Advanced Cancer: What Do Older Patients Believe and How Are These Beliefs Related to Their Preferences?".  This study looked at patients and their beliefs regarding a cure for cancer, specifically in older patients with advanced cancer.  Patients who are certain that they could be cured pose unique challenges for physicians and shows a need for clear communication between patients and their physicians regarding the outcome of treatment and quality of life.

Community Forum


Hi Carole, Welcome to Grace. If the adrenal is the only place that cancer has been seen since your lobectomy it could be that it's what's known as a precocious metastasis/oligoprogression...


These approaches haven't been directly compared, and it really depends on who can do the job and what they say is appropriate to expect in terms of side effects. In...

Hi CDaniele,
Welcome to Grace. If the TKI is working except for one or 2 places local treatment such as radiation can be used to get rid of the resistant cells...

I forgot to tell you that Grace is having its annual OncTalk live forum online Saturday, Dec. 11 at 8 am Pacific and 11 am Eastern
It will be invaluable to...

This is indeed a happy Thanksgiving in our house. I'll post about it at soon but we've just come out of a dark place and are feeling so hopeful today.

Janine I am so happy to hear things like this. What you can or feel comfortable sharing, know that we are here! You are a very important part of the GRACE...

Hi and welcome to Grace.  I'm sorry your sister-in-law is going through this it's so unsettling, to say the least.  Cancer travels through the lymph system but also through blood vessels. ...